← All patents

US20250368999A1

Soluble interleukin-7 receptor (sil7r) modulating therapy to treat cancer

University of Texas System

Abstract

The present invention includes compositions and methods for treating an autoimmune disorder or a cancer in a subject in need thereof, the method comprising: administering an effective amount of a composition comprising an oligonucleotide that specifically binds a complementary sequence of the …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Mariano A. Garcia-Blanco
Priority date
October 29, 2020
Filing date
October 29, 2021
Publication date
December 04, 2025
Language
en
Metadata fetched
August 29, 2026 00:35